Pfizer oral weight loss drug may be as effective as, quicker than Ozempic injection by Novo Nordisk, study says
15 Articles
15 Articles
Forget Ozempic injections — a pill version of the weight loss drug could be coming soon
Iryna Veklich, Getty Images A daily pill version of the medicine that's in the popular drug Ozempic could be coming soon. It's designed to promote weight loss in overweight and obese adults without a weekly shot. Results of a large trial suggest people achieved around 15% weight loss after about 1 year. A once-daily pill version of the drug popularly known as Ozempic is one step closer to market.Drugmaker Novo Nordisk announced the results of a…
Novo Nordisk says trial of oral weight-loss drug shows significant result
COPENHAGEN -- Novo Nordisk said on Monday a late-stage trial of an oral version of its drug semaglutide for weight loss has shown statistically significant and superior weight loss when compared to a placebo.
Pfizer's diabetes drug results in similar weight loss levels as Novo's Ozempic
Pfizer Inc's diabetes drug resulted in weight loss similar to that of Novo Nordisk's Ozempic in a mid-stage study testing it in patients with type 2 diabetes, according to data published in a medical journal.
Coverage Details
Bias Distribution
- 50% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage